Complementary medicine continues to increase in popularity in the general community. As a result it is likely that requests for the administration of complementary medicine to intensive care patients will be more frequent in the future. It is therefore prudent for intensive care clinicians to address this issue and develop an approach that is consistent.
The use of complementary medicine is widespread in the community and its popularity continues to grow. In 1993 the annual expenditure for complementary medicine in Australia was $621 million compared with patient contributions of $360 million for drugs on the Pharmaceutical Benefits Scheme 1 . Expenditure on complementary medicine use has since risen to over $1 billion, with at least 50% of the Australian population using a complementary medicine each year 2 . A survey in 1997 showed that 80% of general practitioners in Australia had referred patients to complementary medicine practitioners 3 .
The Internet provides an almost boundless source of medical information for even a novice user. While this represents a tremendous resource for families of patients who wish to learn more about an illness, in the vast majority of cases this information is not subject to any editorial review or scientific scrutiny. Thus it may be entirely misleading or inaccurate, and may lead to confusion and damage to the doctor-patientfamily relationship. In addition, there is a growing number of dubious health claims for products on the Internet which regulatory authorities are powerless to control 4 . This availability of information, both accurate and false, is coupled with the increasing empowerment of lay people to dictate their therapy and the growing popularity of complementary medicine. Thus requests for the administration of complementary medicine in intensive care patients will probably occur with increasing frequency in the future. It would therefore be prudent for practitioners in intensive care to address the issues, both ethical and legal, surrounding the administration of complementary medicines to critically ill patients. This paper reviews the ethical and legal difficulties that may arise when complementary medicine is requested for intensive care patients. It outlines an approach that may be followed when complementary medicine is requested in an intensive care patient, setting out both the legal and ethical rationale.
COMPLEMENTARY MEDICINE
What is complementary medicine, what sets it apart from conventional medicine and should we attempt to facilitate its use in intensive care?
Complementary medicine is also referred to as "alternative medicine" or "complementary and alternative medicine". These terms encompass a very broad group of treatment modalities including aromatherapy, biofeedback, chiropractic manipulation, herbal medicine, homeopathy, hypnotherapy, naturopathy, nutrition therapy, magnetic stimulation, therapeutic touch, and traditional Chinese medicine 5 . The breadth and variation in this field adds to the difficulty of defining and regulating it. No clear definition exists for complementary medicine, but nor does one exist for conventional medicine. The deeper problem is not really definitional, but rather, conceptual or operational: what are we trying to convey by using terms like "alternative" and "complementary", or "conventional" for that matter?
Two items are complementary if taken together they form something which is complete. The question as to what therapies are complementary is therefore always going to be an important empirical question, one not solved by merely naming something as complementary. It seems very unlikely that any two modalities are complementary in the sense of providing a satisfactory complete account. The term "alternative" really fares no better, since it clearly denotes another means for arriving at some common goal. Genuine alternative routes can be found for the journey between two cities, just as two therapies may be genuine alternatives in some treatment plan. However, the idea that two entire modalities (alternative and conventional) might be alternative is clearly nonsense.
Eisenberg et al define complementary medicine as "medical interventions not taught widely at U.S. medical schools or generally available at U.S. hospitals" 6 . Angell and Kassirer suggest that definition is unsatisfactory since many complementary therapies have entered the medical mainstream, being taught in medical schools and offered by many health insurers 7 . They suggest that the distinguishing feature of complementary medicine is that the therapies have not been scientifically tested. This is further elaborated by Gruner, who defines complementary medicine as "any health therapy that to date does not have robust scientific best available evidence of its efficacy and safety" 8 . Clearly, what is called "conventional".... medicine utilizes many treatments that have not been rigorously tested. However, the "conventional" medicine community generally recognizes this as a problem needing to be remedied. The principle of translating up-to-date information into better medical care is central to the widespread international drive under the banner of evidence based medicine 9 . In contrast, many advocates of complementary medicine consider that the scientific method is not applicable to their therapies and instead they rely on anecdotes and theories 7 . However this situation appears to be changing.
Evidence-Based Complementary Medicine?
In 1992 in the United States, an Office of Alternative Medicine was established in the National Institutes of Health to evaluate complementary therapies. Angell and Kassirer noted that of the 30 research grants awarded by the office in 1993, only nine had resulted in published papers by 1998 and none of these was a controlled clinical trial which would allow any conclusions to be drawn about efficacy. However it appears that there may be an increase in the level of original research activity in complementary medicine and possibly a trend toward an evidence-based approach, as demonstrated by an increase in the number of reports of clinical trials in complementary medicine in the scientific medical literature 10, 11 . If complementary medicine therapies prove to be effective and safe in well conducted clinical trials, then, being grounded in scientific research, they will come under the umbrella of conventional or evidence-based medicine.
In the U.S., most complementary medicines are regulated separately from food and medicines. The Dietary Supplement and Health Education Act (1994) is used to regulate most complementary medicines. This regimen does not test the medicines for safety or quality and these medications must carry a warning that the product has not been tested by the US Food and Drug Administration (FDA) 12 .
Canada has recently announced a similar type of regulatory model for complementary medicines. An Office of Natural Health Products is being established 13 . New Zealand is integrating complementary medicines with other medicines and testing all medications for efficacy rather than regulating them on a separate level. In Germany complementary medicines are treated as prescription medicines and regulated accordingly 12 . In the United Kingdom, information on complementary medicine has been sent to general practitioners by the Department of Health. Covering the six kinds of complementary therapy most often provided in the NHS, the guidance is designed to help doctors make informed decisions about herbal medicine, acupuncture, osteopathy, homeopathy, chiropractic, and hypnotherapy and aromatherapy 14 .
In Australia, the Office of Complementary Medicine was established in early 1999. It is part of the Therapeutic Goods Administration and is the regulator of complementary medicine. There has been a Complementary Medicines Evaluation Committee (CMEC) since December 1997. In 1999 the Complementary Healthcare Consultative Forum and a Complementary Healthcare Council were established. There is now a database of known drug interactions that involve complementary medications. More information is being made available about complementary medicine and clinicians can consult the Office of Complementary Medicine within the Therapeutic Goods Administration about medications. The Adverse Drug Reactions Advisory Committee (ADRAC) also publishes bulletins and alerts of known drug interactions with complementary medicines.
One of the most common complementary therapies is herbal medicine 15 . Until the 20th century most medical treatments were botanicals, some of which were found, by trial and error, to be useful. Advances in chemistry and pharmacology in this century saw the isolation of the active agents in many botanicals. Hence, amongst others, digitalis was extracted from foxglove, morphine from the opium poppy and quinine from cinchona bark. The 20th century also saw the introduction of powerful epidemiological tools for testing therapeutic interventions to determine their efficacy, side-effects and indications. Before a drug is approved for use by the Therapeutic Goods Administration it must undergo rigorous phase one (to determine its adverse effects), phase two (to determine its efficacy) and phase three (comparison with placebo) trials. The result of these advances in medical therapies has been dramatic. In less than a century, life expectancy in the Western world has increased dramatically, partly because of improved sanitation and living standards, but at least in part because of advances in medicine as a result of rigorous testing. Complementary medicine therapies are not subject to the same standards, either in testing or manufacture.
The Australian Therapeutic Goods Act 1989 requires that Aust R and Aust L numbers are placed on all goods and devices that make therapeutic claims. An Aust R (for "Registration") number requires the rigorous testing and evidence of efficacy described above. However an Aust L (for "Listing") number requires no evidence to support therapeutic claims. In fact there is little or no legislative backing for the Therapeutic Goods Administration to require evidence of efficacy for listed products 16 . In the U.S.A. homeopathic remedies and dietary supplements have been exempted from FDA regulation. As a result homeopathic agents may not even contain the agents listed on the label. For example, an analysis of ginseng products showed that the content of active ingredient in different brands varied widely and in some brands there was none at all 17 .
In Australia the manufacture of complementary medicines may be regulated under the Therapeutic Goods Act Section 36, which allows the Minister to regulate principles of manufacture relevant to the quality, safety and efficacy of therapeutic goods for use in humans 18 .
Fortunately most untested complementary therapies will probably not have significant adverse effects. In addition they are generally used by people who are healthy or have relatively minor, not lifethreatening maladies. Thus in most cases, the complementary therapies will do no harm. However, the use of complementary medicine in the face of significant illness may have adverse consequences as a result of delay in therapeutic intervention or failure to seek conventional medical therapy 19, 20 . Although complementary medicines are often perceived as being "natural" and therefore harmless, this is clearly not always the case. Adverse effects reported include allergic reactions, toxic reactions, adverse effects related to the agent's desired pharmacological actions, possible mutagenic effects, drug interactions and mistaken plant identities 21, 22 . In addition, inadequate quality control in the manufacture of some complementary medicines has resulted in inconsistencies in composition, adulteration with other compounds and contamination with heavy metals and other toxins [23] [24] [25] .
The Popular Appeal of Complementary Medicine
Given the apparent uncertainty regarding efficacy and safety of complementary medicine, why is it that its use is so widespread and its popularity appears to be increasing 26, 27 ? Part of the reason may be a degree of disillusionment with the often rushed, impersonal and focused (as compared to holistic) treatment provided by practitioners of conventional medicine, as well as the unpleasant nature of therapies which may be necessary for life-threatening illnesses.
Complementary medicine has a persuasive attraction for many people in the Western world. Independent of any considerations of efficacy the consumers appear to be attracted by the power of the underlying cultural themes and practices offered by complementary medicine. Kaptchuk and Eisenberg outline fundamental themes that underlie complementary medicine including nature (where a natural remedy is considered wholesome, innocent and virtuous), vitalism, spirituality and "science" 28 . Science does not have to be abandoned when using complementary medicine. In fact science is an important source of legitimization and authority as evidenced by the long intellectual tradition of some complementary disciplines, such as acupuncture, homeopathy and herbal medicine. Contributing to the scientific claim is the fact that training in disciplines of complementary medicine may involve years of study of complex knowledge bases. However, the science of complementary medicine generally does not embrace the medical approach of performing experiments under artificially controlled conditions (epitomized by the randomized, double-blind placebo-controlled trial). Instead the complementary medicine version of science is observational, anecdotal and ignorant of biologic mechanisms.
It is vital to the practitioner of conventional medicine to attempt to understand why patients are attracted to complementary medicine, as they need to counsel, negotiate and provide medical care. Given the widespread use of complementary medicine, the absence of a respectful and considerate attempt to communicate across cultural medical barriers may undermine the maintenance of a good doctor-patient relationship.
LEGAL ASPECTS
A finding of medical negligence requires the injured party to prove to a court, on the balance of probabilities, that their injury was caused by the clinician. The injured party must prove to the court that: 1) the clinician owed them a duty of care; 2) the clinician breached that duty of care by falling below an acceptable standard of care (determined by a court); and 3) that the breach caused the injury. Attending clinicians owe the patient a non-delegable duty of care to provide for all of the patient's medical needs. This duty is a comprehensive one at both common law and in legislation, extending to consent, ensuring patient safety, competent diagnosis, treatment and follow-up.
There is very little legislation regulating consent to medical treatment. The most comprehensive legislative treatment of this area is found in South Australia. In South Australia "medical treatment" is defined in the Consent to Medical Treatment and Palliative Care Act 1995 as "treatment or procedures administered or carried out by a medical practitioner in the course of medical or surgical practice … and includes the prescription or supply of drugs" 29 .
Section 15 of the Act sets out the requirements for consent by all medical practitioners:
A medical practitioner has a duty to explain to a patient (or the patient's representative), so far as may be practicable and reasonable in the circumstances-(a) the nature, consequences and risks of proposed medical treatment; and (b) the likely consequences of not undertaking the treatment; and (c) any alternative treatment or courses of action that might be reasonably considered in the circumstances of the particular case.
Suggestions that sub-section (c) above may include a requirement to discuss alternative or complementary therapies is unsupported by a reading of the definition of medical treatment of the Act. Reading Section 15 of the Act in conjunction with the definition of medical treatment suggests that the legislature only intended medical and dental practitioners in South Australia to be explaining treatments that are part of the course of proper medical, surgical and dental practice. In the Australian Capital Territory, Section 11 of the Medical Treatment Act establishes a similar requirement that health professionals (currently defined as registered medical practitioners and nurses) explain the nature of the treatment, the consequences of not having the treatment, and any reasonable alternatives 30 . Again, there appears to be no suggestion in the Act that complementary therapies would fall within the ambit of alternative treatments.
Section 16 of the Consent to Medical Treatment and Palliative Care Act 1995 (SA) contains protections for medical practitioners generally who act in good faith, without negligence and in accordance with "professional standards of medical practice". The actions of the clinician are therefore judged by "proper professional standards of medical, dental or surgical practice, or palliative care". This immediately raises the problematic question: is the provision of complementary health care consistent with such standards? These issues are largely decided by the relevant disciplinary boards, but appeals from these decisions may be heard by courts.
In other Australian jurisdictions, one must look to the common law cases for guidance in this area. Again, there is little or no authority on the matter. There may be guidance from Medical Boards or indeed from cases heard by the Boards 31-34 . Health Complaints Commissions may also field complaints about medical practitioners using complementary medicine as well as complaints against complementary healthcare providers 35 .
Unprofessional Conduct
Medical Boards are concerned with regulating the profession and ensuring compliance with regulatory legislation. They define conduct that falls below their required standard variously as "unprofessional conduct", "unsatisfactory professional conduct", "misconduct in a professional respect", or "professional misconduct" 36 .
Regulation of medical professionals has often depended on judging the practitioners' standards with those of peers. Growing acceptance of alternative therapies by medical practitioners may pose problems in this area. In the Northern Territory the Medical Practitioners Registration Act defines unprofessional conduct to include "any conduct which may be considered to be unprofessional according to the standards of good medical practice and professional behaviour and the ethics of the medical profession" 37 . The Victorian Medical Practice Act defines unprofessional conduct to include "professional conduct which is of a lesser standard than that which might reasonably be expected of a medical practitioner by her or his peers" 38 . Although peer practice is often a good determinant of assessing a practitioner's conduct and performance at the Medical Board, courts are free to make decisions independently of such standards.
Regulatory legislation establishes clear definitional boundaries for medical practice. In fact, registration as a medical practitioner in all Australian jurisdictions is conditional on the applicant completing a medical degree at an approved university 39 . However, it is interesting to note the growth of complementary therapies in the teaching curricula of medical schools. Half the universities in the U.K. and almost all the U.S. medical schools have devoted some curriculum space to complementary treatments 40 .
Queensland's Medical Practice Act Section 35 defines "misconduct in a professional respect" to include knowingly enabling any person other than "a recognised medical practitioner or specialist, medical student, dresser, midwife, nurse, surgery attendant, masseur or masseuse" to treat a patient. This provision does not permit medical practitioners to use complementary therapies (other than massage therapy) nor to direct others to administer them. A similar provision exists in the Medical Practitioners Act 1930 (A.C.T.) Section 35 and in the Medical Practice Act 1992 (N.S.W.) Sections 36 to 38. The N.S.W. and A.C.T. provisions differ from the Queensland ones only in that massage therapy is not permitted.
Legislation regulating medical practitioners would not appear to sanction treatment falling outside the practice of medicine. The use of untested treatments and medications would probably constitute unprofessional conduct. The Medical Board of South Australia appears to agree. The Board has stated that incompetence or negligence may be proven by "practising in an area of medicine which is outside the expertise and training of the practitioner" 41 . In 1999 the Medical Board of South Australia released a statement to all medical practitioners warning of the use of scientifically unproven therapies. The Board statement indicated that medical practitioners should only use equipment or techniques that have been scientifically proven and that experimental or unproven techniques only be used in properly authorized formal clinical trials 32 .
The Medical Board of Queensland issued a policy document to medical practitioners in August 1999 setting out guidelines for the use of complementary, alternative, or unconventional medicine 31 . The document is adapted from a similar policy document issued by the Medical Council of New Zealand. It stresses the need for medical practitioners to distinguish between evidence-based medicine and unproven treatments, and for medical practitioners to aim to provide as much treatment as possible in accordance with evidence-based guidelines or practices.
A doctor who chooses to recommend an unproved or experimental treatment ahead of one with proved effectiveness must have broad professional support in doing so (the first renal transplant, for example) as well as both the fully informed patient's acceptance of the experimental treatment and the sanction of a formally constituted ethics committee. In the absence of these safeguards, the practitioner must be prepared to argue, with evidence, that the experimental or unproved treatment is safe, and that the patient is not harmed by withholding the standard therapy 31 .
If no treatment has been proven to be effective, as is common in intensive care patients, the Queensland guidelines suggest that a treatment that involves any risk to the patient, similarly requires written consent and approval from an ethics committee.
The Queensland Board guidelines clearly suggest that a medical practitioner adopting or advocating complementary, alternative or unconventional medicine could be found guilty of incompetent treatment. The practitioner's advice will be judged according to criteria that is similar to the NHMRC guidelines for providing information to patients 42 and the medical treatment is to be judged by medical standards of evidence based medicine.
The Medical Board of the Northern Territory issued guidelines in 1999 on the use of alternative therapies, based on the Victorian Medical Practitioner's Board 33, 34 . These advise that special care must be taken to inform patients when the therapy is unproven and to fully inform patients of any risks associated with such therapy. In addition, "for alternative therapies with risks of serious side-effects, the patient should be advised to seek a second independent medical opinion" and "patients who are offered alternative remedies must not be denied access to standard proven therapies of a type which would be provided by most medical peers".
In the United States, resolution of these issues is far more advanced. Bills have been introduced into the state legislatures of California, Nebraska, Ohio and Louisiana that provide that the use of complementary medicine by medical practitioners is not unprofessional conduct per se 43 . Only Ohio has so far managed to pass such legislation into law. This has been a response to widespread legislation that prohibited non-medically trained practitioners practising any area of medicine 44 . Professional regulation of complementary healthcare practitioners is now widespread in the United States. California, for example, regulates 32 allied healthcare professionals including "drugless practitioners", "osteopathic physician assistants" and "medical device retailers" 44 . Managed care organizations are already offering complementary and alternative medicine within health care groups. There is further regulation of these practitioners by the managed care organizations. Congress proposed Access to Medical Treatment Act (AMTA) will allow consumers to have access to drugs and medical devices that are not approved by the FDA. The AMTA will allow patients access to the treatment providing it is within the practitioner's competency and that it has not proven harmful to patients 45 .
By contrast, Australia has minimal professional registration of complementary medicine, but this is likely to change in the near future. Practitioners once considered to be alternative are now becoming integrated and are regulated. For example, in South Australia the Workers Rehabilitation and Compensation Act defines a medical expert as a registered medical practitioner, dentist, psychologist, optician, physiotherapist, chiropractor, podiatrist, occupational therapist or speech pathologist 46 . The Guardianship and Administration Act 1993 (S.A.) has also recently had a definition of "health professional" inserted that encompasses chiropractors and chiropodists 47 . Complementary medicine practitioners received a boost in Victoria with the enactment of the Chinese Medicine Registration Act 2000. This Act drew on a template designed by the Victorian parliament to regulate other complementary practitioners 48, 49 . A registration board is established and there is a definition of "unprofessional conduct". Similar options have been explored in the Australian Capital Territory 50 . There are signs of some acceptance by government and by insurers of alternative medical practices. There has also been reasonable acceptance of certain complementary treatments by general practitioners in Australia 3 . Certain complementary medical treatments were also granted an exemption from having the GST levied on them until July 2003. These were acupuncture, naturopathy and herbal and Chinese medicines. To obtain the exemption the supplier of these services must meet all the educational and professional qualifications required of that practitioner 51 .
Malpractice Insurance Liability Issues
Medical indemnity insurance only covers medical practitioners for acts done in the normal course of employment as a medical practitioner. One has to ask whether the use of complementary medicine would fall within such a definition. An insurance exclusion commonly exists where a medical practitioner incurs a claim based on a breach of a duty assumed if that duty is not normally assumed by practitioners of their profession, or if the claim arises from procedures not associated with the practitioner's category of membership. Whether this would include the use of complementary medicine is uncertain.
Within public hospitals, the state indemnifies its employees for duties performed in the course of their lawful employment. It is likely that few doctors at public hospitals would be sure of, or even able to obtain a ruling about, the use of certain complementary medicines.
Common Law Standard of Care
Until there is further regulation of complementary medicine, clinicians are left to resolve the issues according to their own understanding of the standard of care they should provide. The standard of care required at Australian common law for both the provision of information and the provision of medical treatment by medical practitioners was recently restated by the High Court in Naxakis v Western General Hospital 52 :
The Bolam rule, which allows that the standard of care owed by a doctor to his or her patient is "a matter of medical judgment", was rejected by this Court in Rogers v Whitaker. In that case it was pointed out that, in Australia, the standard of care owed by persons possessing special skills is that of "the ordinary skilled person exercising and professing to have that special skill [in question]". In that context, it was held that "that standard is not determined solely or even primarily by reference to the practice followed or supported by a responsible body of opinion in the relevant profession or trade".
The standard of care required in intensive care is therefore that of the ordinary skilled intensivist. It is a standard that will be assessed by the courts. If the standard of care is no longer dependent on bodies of professional opinion or practice, this would presumably allow the court to assess the standard of care independent of a disciplinary board finding of unprofessional conduct. It has yet to be decided by Australian courts whether it would be appropriate intensive care treatment to provide a patient access to complementary medicine.
The standard of care required of a complementary therapist is clearly lower than that of a medical practitioner, even where they are offering the same treatment. This was confirmed in a recent English judgement 53 . In this case, the patient had a skin condition and consulted a practitioner of Chinese herbal medicine. He was prescribed a classical herbal remedy. After nine doses the patient became very ill and later died of liver failure attributed to a rare and unpredictable reaction to the treatment. His widow brought an action alleging negligence both in the treatment and in failing to warn of the risks. She was unsuccessful as the judge ruled that although there was evidence of this risk in medical journals, the practitioner would not be held to this standard.
A recent study from the United States showed that lawsuits against complementary practitioners are less frequent and the damages awarded are less than those awarded against conventional medical practitioners 54 . The authors concluded that this was primarily due to the fact that procedures conducted by complementary practitioners are less invasive, the dynamics of the consultation and treatment are very different, and the case law involving complementary medicine is largely undeveloped.
Consent to Complementary Treatments
Clearly, the use of complementary treatments is potentially fraught with danger. The clinician must be able to explain the nature, consequences and risks of any proposed treatment. If a clinician is unfamiliar with the alternative treatment to be administered then he or she will be unable to properly explain these matters. If this is not done, then consent may not be obtained and the clinician will be exposed to liability for assault of the patient by administering the treatment. Alternatively, the clinician could be exposed to a common law action in negligence for failure to warn of a risk that eventuated, or a claim based on a failure to inform the patient that they were using a treatment outside their scope of medical practice. This assumes that it is not unprofessional practice to even be using complementary therapies.
If there are concerns about potential adverse effects of any complementary therapies, the clinician's duty is to avoid exposing the patient to those risks. Hence any request to administer complementary medicine should be refused if it might place the patient's health at risk.
There is no legal obligation to carry out a request by a patient or family for complementary therapy. It may appear inconsistent with the patient's right to choose between different modalities of treatment if these principles of duty of care are strictly followed. However, this is different from the situation where the patient is given a choice between a number of conventional therapies in which the attending doctor possesses expertise. If a clinician has no experience or knowledge regarding a therapy, he or she should inform the patient or patient's representative that the clinician is unable to participate in the administration of the treatment. If the patient is insistent on the complementary therapy, transfer to another facility that is experienced in the therapy may be offered. If such a transfer is to occur, the patient or representative should be advised of the consequences of ceasing the established therapy and they should sign a state-ment that they are leaving the hospital against medical advice. In the setting of intensive care, with patients dependent on high levels of invasive support, such a transfer will not often be possible.
The position of the intensive care patient is considerably different from that of the ambulant patient. An ambulant patient may choose to self-administer complementary medicines and it will generally be impossible to prevent self-administration without significantly impinging on their rights. An analogy is the patient who chooses to smoke while an inpatient of the hospital. If the patient chooses to self-administer complementary medicines, the attending clinician should counsel the patient regarding potential risks and record that the counselling has occurred. Clearly such a solution is not applicable to the intensive care patient who is generally unable to self-administer medications and whose care is constantly managed by nurses under the supervision of an intensive care clinician. Thus an intensive care patient can only receive complementary medicines with the knowledge and authorization of the intensive care clinician. A medical officer authorizing any treatment is responsible for any adverse effects of that treatment.
Allowing the patient's family or other representative to administer the treatment does not provide a solution. If the patient should suffer adverse effects as a result of the administration of complementary medicine by a family member with the knowledge and therefore approval of the intensive care clinician, the clinician may be found to have breached the nondelegable duty of care owed to the patient. Administration of compounds by the family in hospital would be prima facie a breach of the duty of care to ensure that only medicines consistent with the good medical standards of the clinician are administered.
If the clinician refuses to allow the administration of complementary medicine to the patient, he or she should not incur any civil or criminal liability. The complementary medicine is not in the nature of medical treatment administered by the clinician and so it is unlikely that a court would find any legal liability in the clinician for refusing to allow its administration. The clinician is under no obligation to administer complementary medicine according to the family's wishes if it is contrary to the clinician's nondelegable duty of care because of attendant potential risks.
In considering requests for complementary medicine, the intensive care clinician must attempt to find a balance between strong and sometimes competing ethical imperatives. The clinician's active concern for the safety and well-being of the patient is obviously first among them. Despite the fact that it is a central part of good medical practice, the imperative to sensitively deal with the patient's family clearly does not override the demands of safety. Safety and sensitivity are therefore lexically ordered in the ethics of requests for complementary medicine in intensive care patients. The intensive care clinician must attempt to negotiate the question of safety in light of the autonomy that might find expression in the wishes of the patient and the family.
It is possible to allow the administration of complementary medicine if a number of conditions are met. The patient, family or patient's representative must be fully advised of the potential risks to the patient's health; in addition, a written acknowledgement must be obtained stating that the risks have been explained, that such treatment is against medical advice and that the family or patient's representative absolves the hospital and medical officers of any responsibility. In this situation the hospital and attending clinicians could have a defence of voluntary assumption of risk (volenti non fit injuria). This is a complete defence provided that it can be clearly established that: 1. the patient (or patient's representative) perceived the existence of the danger 2. the patient (or patient's representative) fully appreciated the nature of the risks 3. the patient (or patient's representative) voluntarily accepted the risks It is important to establish the risks that the patient has voluntarily accepted, as the acceptance of one risk does not necessarily imply the acceptance of all risks.
In the United States, assumption of risk forms have been used by doctors where requests for complementary therapies are made. Figure 1 shows an example from a suggested consent form 55 .
AN APPROACH TO COMPLEMENTARY MEDICINE IN INTENSIVE CARE
Intensive care medicine utilizes some of modern medicine's most highly technical and invasive therapies. Whilst most therapies used in intensive care are based on a scientific approach, it is certainly true that not all are evidence-based. Often this is because the evidence simply does not exist. However this deficiency is recognized and the intensive care community is attempting to address it. Thus, as a result of well-conducted trials we have seen the para-meters for blood transfusion change 56 , the use of dopamine questioned 57 and the prophylaxis of stress ulceration change 58 , among others.
This increasing drive towards evidence-based medicine is appropriate since it provides benefits for practitioners, administrators and, most importantly, patients. Practitioners will have their work facilitated by clearer delineation of efficacy and risks of therapies, and possibly a degree of standardization of the therapeutic approach to a clinical problem. Health administrators can use evidence-based medicine to determine the cost effectiveness of treatment modalities. Patients can be provided with clear information on risks and benefits and alternative therapies. Thus they will be better equipped to make informed decisions on their treatment. In addition they should benefit by the increased precision of their treatment with, presumably, an improvement in outcome, although this has not yet been demonstrated.
Complementary medicine, as discussed earlier, does not follow an evidence-based approach. As a result, decisions about its use cannot be based on risk/benefit analyses, its use cannot be incorporated into protocols for standardized care, its cost effectiveness cannot be determined and genuine informed consent is not possible. For all of these reasons, complementary medicine should not be incorporated into intensive care practice. If a complementary mode of therapy is subjected to rigorous testing and found to be effective and safe, then it should be considered for 235 
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Anaesthesia and Intensive Care, Vol. 29, No. 3, June 2001 use in intensive care patients. In such a circumstance that mode of therapy would have left the realm of complementary medicine, if one considers that "complementary medicine" refers to therapies that have not been scientifically tested 7 . The intensive care clinician is under no legal obligation to administer complementary medicine requested by the patient or family, particularly if he or she considers it may expose the patient to risk. Whilst such an approach may be legally defensible, a complete refusal to administer complementary medicine in intensive care negates the right of the patient and family to choose between treatments. In addition it fails to recognize the reasons for the request and the psychological impact the treatment, or failure to administer the treatment, may have on the patient and family.
The scientific counter argument to this is, "what does it matter if the evidence shows that refusal to provide complementary medicine is the right course of action and the patient's outcome is improved as a result"? But optimal treatment of an individual patient may not translate into a satisfactory outcome as perceived by the patient or the family 59 . Thus the patient or family must endure the trauma of an intensive care stay which may result in death or disability, despite ideal evidence-based care. As a consequence they may be left with feelings of guilt, anger or disappointment and these emotions may be exacerbated if a request for complementary medicine is dismissed without demonstrable reason. In addition the damage done to the doctor-patient-family relationship may be significant.
The arguments in favour of evidence-based medicine and against complementary medicine are powerful and it is clear that if one wishes to maintain the most readily defensible legal position, one should not embrace requests for administration of complementary medicine in intensive care patients. However the intensive care clinician should respond to requests with respect and compassion. An attempt should be made to address the basis for the request and to explain the reasons for not carrying out the complementary therapy.
If the patient or family is insistent on the treatment then the response will be dependent on the nature of the patient's illness and the proposed complementary therapy. A request for a therapy that is simple and clearly harmless, such as crystals, magnets or some aromatherapies, can generally be acceded to. Therapies that will clearly be harmful cannot be entertained. A more difficult case is the request for therapies that lie between these two extremes, such as enteric or parenteral herbal medicines or high dose vitamins. In this situation, a literature search should be performed to determine the contents of the complementary medicines and exclude known risks. If there are no overt significant risks and it is considered by the intensive care clinician that the administration of the complementary medicine is important to the patient or family and the doctor-patient-family relationship, then complementary medicine could be considered under the following conditions: 1. The family and, if possible, the patient should be fully counselled on the potential risks to the patient's health and of the absence, or otherwise, of evidence of efficacy of the treatment. It is important to identify and discuss all of the potential risks. 2. A document should be signed stating that the risks have been explained, the treatment is against medical advice and that the patient or patient's representative absolves the hospital and intensive care practitioners of any responsibility. This process must establish that the patient or patient's representative was aware of the existence of potential risks, appreciated the significance of those risks and accepted them voluntarily. Given that the patient is owed a duty of care by both the hospital and the intensive care clinicians, the hospital administration and risk managers should be involved in this process and participate in counselling the patient and family.
CONCLUSION
The use of complementary medicine is widespread and its popularity is increasing. In addition, access to the Internet enables our patients and their families to be more informed, if not better informed, about their illness. As a result, it is likely that requests for the administration of complementary medicine to intensive care patients will be more frequent in the future. It is therefore prudent for intensive care clinicians to address this issue and develop an approach that is consistent.
Complementary medicine is distinguished by the absence of well conducted trials to determine its efficacy and risks. As a result, decisions about its use cannot be based on risk/benefit analyses and genuine informed consent cannot be achieved. Therefore complementary medicine should not be incorporated into intensive care practice.
Strict adherence to a policy of negating requests for administration of complementary medicine in intensive care patients may be seen as inconsistent with the patient's right to choose between treatments. Significant damage to the doctor-patient-family relationship may result. Patients or families should be counselled about the risks and efficacy of the suggested complementary therapy and, in general, the advice should be against its use. On occasions the patient or family may insist on the use of complementary medicine and it may be seen as important to their psychological well-being to accede to the request. The intensive care clinician still owes the patient a duty of care and is still legally responsible for any treatment administered to the patient, even if it is against his or her advice. However if there is no demonstrable risk to the patient, complementary medicine can be administered following appropriate counselling and documentation.
